0001601485-22-000011.txt : 20220304 0001601485-22-000011.hdr.sgml : 20220304 20220304162024 ACCESSION NUMBER: 0001601485-22-000011 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220302 FILED AS OF DATE: 20220304 DATE AS OF CHANGE: 20220304 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CURHAN GREGORY S CENTRAL INDEX KEY: 0001263244 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39990 FILM NUMBER: 22714324 MAIL ADDRESS: STREET 1: 600 CALIFORNIA STREET, 9TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94108 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Angion Biomedica Corp. CENTRAL INDEX KEY: 0001601485 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113430072 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 51 CHARLES LINDBERGH BOULEVARD CITY: UNIONDALE STATE: NY ZIP: 11553 BUSINESS PHONE: (415) 655-4899 MAIL ADDRESS: STREET 1: 51 CHARLES LINDBERGH BOULEVARD CITY: UNIONDALE STATE: NY ZIP: 11553 4 1 wf-form4_164642880552681.xml FORM 4 X0306 4 2022-03-02 0 0001601485 Angion Biomedica Corp. ANGN 0001263244 CURHAN GREGORY S C/O ANGION BIOMEDICA CORP. 51 CHARLES LINDBERGH BLVD. UNIONDALE NY 11553 0 1 0 0 See Remarks Stock Option (Right to Buy) 1.99 2022-03-02 4 A 0 100000 0 A 2032-03-01 Common Stock 100000.0 100000 D The total number of options vest in forty-eight (48) successive and equal monthly installments as measured from March 3, 2022 (the "Vesting Commencement Date"), such that 100% of the options will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. Chief Financial Officer /s/ Jennifer J. Rhodes, as attorney-in fact for Gregory S. Curhan 2022-03-04